Hospital Clinico Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (69)

2024

  1. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  2. Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry

    Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264

2022

  1. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study

    Alimentary pharmacology & therapeutics, Vol. 55, Núm. 11, pp. 1402-1413

  2. Autoimmune hepatitis triggered by COVID-19

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 64-65

  3. Caustic Ingestion: A Risk-Based Algorithm

    The American journal of gastroenterology, Vol. 117, Núm. 10, pp. 1593-1604

  4. Long-term evolution of continence and quality of life after sphincteroplasty for obstetric fecal incontinence

    Annals of Coloproctology, Vol. 38, Núm. 1, pp. 13-19

  5. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  6. Reply

    Diseases of the Colon and Rectum

  7. Thiopurine adherence: a high prevalence with low impact on UC outcomes

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 2, pp. 76-82

2021

  1. Botulinum Toxin Injection Plus Topical Diltiazem for Chronic Anal Fissure: A Randomized Double-Blind Clinical Trial and Long-term Outcome

    Diseases of the colon and rectum, Vol. 64, Núm. 12, pp. 1521-1530

  2. Caustic ingestion: Development and validation of a prognostic score

    Endoscopy, Vol. 53, Núm. 8, pp. 784-791

  3. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry

    Digestive Diseases and Sciences, Vol. 66, Núm. 6, pp. 2014-2023

  4. Factors associated with quality of care in inflammatory bowel diseases: a view from patient’s side using the IQCARO quality of care decalogue

    BMC Gastroenterology, Vol. 21, Núm. 1

  5. Patient-Evaluated Quality of Care is Related to Better Inflammatory Bowel Disease Outcomes: The IQCARO II Project

    Patient, Vol. 14, Núm. 5, pp. 625-634

  6. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt

    Digestive and Liver Disease, Vol. 53, Núm. 12, pp. 1596-1602

  7. Transjugular intrahepatic portosystemic shunt reduces hospital care burden in patients with decompensated cirrhosis

    Internal and Emergency Medicine, Vol. 16, Núm. 6, pp. 1519-1527

2020

  1. Clinical assessment of risk factors for infection in inflammatory bowel disease patients

    International Journal of Colorectal Disease, Vol. 35, Núm. 3, pp. 491-500

  2. Correction to: Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry (Surgical Endoscopy, (2020), 34, 3, (1112-1122), 10.1007/s00464-019-06858-z)

    Surgical Endoscopy

  3. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  4. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry

    Surgical Endoscopy, Vol. 34, Núm. 3, pp. 1112-1122